Katalin Kelemen Selected Research

Katalin Kelemen Research Topics

8	Neoplasms (Cancer) 04/2022 - 01/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2012
3	Eosinophilia 01/2021 - 01/2018
2	Leukemia 04/2022 - 01/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 07/2017
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2004 - 11/2002
1	Genomic Instability 04/2022
1	HIV Infections (HIV Infection) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Blast Crisis (Blast Phase) 01/2021
1	Mastocytosis 01/2021
1	Chromothripsis 01/2020
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2019
1	Bronchiolitis Obliterans 01/2018
1	Castleman Disease (Castleman's Disease) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Hodgkin Disease (Hodgkin's Disease) 02/2017
1	Agranulocytosis (Granulocytopenia) 10/2014
1	Philadelphia Chromosome 06/2014
1	Acute Promyelocytic Leukemia 05/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 07/2010
1	Lymphoma (Lymphomas) 03/2009
1	Disease Progression 03/2009
1	Hemorrhage 11/2004
1	Prediabetic State (Prediabetes) 03/2004

2	AutoantigensIBA 03/2004 - 11/2002
1	NucleophosminIBA 01/2022
1	Core Binding Factors (Core-Binding Factor)IBA 01/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Pharmaceutical PreparationsIBA 07/2017
1	Immunomodulating AgentsIBA 07/2017
1	Azathioprine (Imuran)FDA LinkGeneric 07/2017
1	Amitriptyline (Elavil)FDA LinkGeneric 10/2014
1	AntigensIBA 07/2010
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 07/2010
1	Capsules (Microcapsules)IBA 11/2004
1	HLA-DQ8 antigenIBA 03/2004
1	Histocompatibility Antigens Class IIIBA 03/2004

7	Therapeutics 04/2022 - 05/2012
3	Cell Transplantation 04/2022 - 06/2014
2	Transplantation 04/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 05/2017 - 03/2009
1	Organ Transplantation 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Salvage Therapy 05/2017
1	Heart Transplantation (Grafting, Heart) 07/2010
1	Laparotomy 01/2004